Unique Advantages of Incorporating Untargeted and Targeted Metabolomics in Drug Development and Clinical Trials
How United Therapeutics leverages metabolomics to get closer to the phenotype increasing confidence in clinical trial decisions
Deeper Understanding of COVID-19 Phenotypes Through Metabolomics: A Panel Discussion
How are researchers studying COVID-19 using metabolomics to get closer to the phenotype?
Untargeted Metabolomics in Feces a Functional Readout of Gut Microbial Activity
Featuring Annie Evans, Ph.D
Secret Weapon – Interrogating Host Pathogen Interactions with Precision Metabolomics
Featuring Geoffrey Feld, Ph.D
Quality Control and Assurance in Untargeted Metabolomics
Featuring Annie Evans, Ph.D
Precision Metabolomics: Current State and Future Plans
Featuring Luke Miller, Ph.D
Overcoming Challenges in Microbiome Research: A Panel Discussion
Featuring Nikole E. Kimes, PhD, President, CEO & Co-founder at Siolta Therapeutics, Eran Segal, Ph.D., Professor at Weizmann Institute of Science, and Greg Michelotti, Ph.D, Scientific Director of Biology at Metabolon, Inc.
Metabolomics as a Leading Technology in Biomarker Discovery
Featuring Dr. Brian Keppler, Ph.D
Metabolomic Approaches in NASH and NAFLD R&D
Featuring Dr. Jamie Bates of Gilead Sciences and Dr. Kari Wong of Metabolon
How Metabolomic Profiling Can Unlock Gene Function & Provide Biological Insight
Featuring Gregory Michelotti, Ph.D
Harnessing the True Power of Metabolomics with the 4Cs
Featuring Greg Michelotti, Ph.D, Annie Evans, Ph.D, and Kirk Beebe Ph.D
Global Metabolomics & Diabetes: Stories from the Bench to the Clinic
Featuring Kirk Pappan, Ph.D
Mechanisms of Immune Control and Metabolomics
Featuring Vinay Pawar, Ph.D and Ujjwal Neogi, Ph.D., Associate Professor of Virology, Karolinska Institutet and Adjunct Associate Professor, School of Medicine, University of Missouri
Power Your Study For Success
Our experts talk about our well-established best practices and client support solutions that ensure you research the guidance and insights you require to advance your research objectives.
Reflections of the Human Gut Microbiome in the Blood Metabolome
Featuring Sean Gibbons, Ph.D, Assistant Professor at ISB, and Greg Michelotti, Ph.D, Scientific Director of Biology at Metabolon
Understanding Viral Infection & Optimizing Vaccine Development with Metabolomics
Featuring Brian Keppler, Ph.D
Metabolomics and the Microbiome Revolution: Critical Innovations to Unlock Gut Microbial Function in Human Health
Explore how metabolomics enables a unique and critical understanding of gut microbiome function in vivo as well as how recent technical innovations help overcome cold-chain requirements and other challenges related to the collection, storage, and shipping of human fecal metabolomic samples.
Driving COVID-19 Research Forward
Featuring Patricia Sheridan, Ph.D and Dr. James R. Heath, President and Professor at Institute for Systems Biology in Seattle (ISB)
Answering Common Questions About Metabolomics
Featuring Kari Wong, Ph.D, Michael Fanelli, and Vinay Pawar, Ph.D
Metabolomics in Bioprocessing: Enabling Understanding & Control of Active Biology
How metabolomics can be applied across the bioprocess lifecycle from process development to monitoring to gain biological insight and facilitate the development, implementation, and execution of robust and reproducible bioprocesses.